Clinical trials: Sensitivity Training Groups, open to volunteers
Chronic Disease, Therapeutic Adherence
Improving Patients' Adherence to Their Chronic Treatments by Implementing a Simple, Standardized and Redundant Message Delivered by Healthcare Professionals.
The primary objective in this study is to achieve a 15% 6-month improvement in therapeutic adherence among patients with chronic pathologies, thanks to a simple, standardized and redundant message delivered by healthcare…
- Conditions
- Chronic Disease, Therapeutic Adherence, Training Group, Sensitivity, Delivery Simple, Standardized & Redundant Message to Patient
- Trial name
- MAPS (NCT06748118)
- Testing
- Trained healthcare professionals deliver a simple, standardized and redundant 3-point message to patients, based on the levers of action for therapeutic adherence.
- Where
- 10 sites in France
- Volunteers
- 1,210 people
- Sponsor
- Assistance Publique - Hôpitaux de Paris
Acute Lymphoblastic Leukemia, Childhood Leukemia, Acute Lymphoblastic
Newly-diagnosed Pediatric T-cell ALL Protocol
This is a prospective, multicenter study conducted within the Chinese Children's Cancer Group (CCCG). The study aims to evaluate whether the addition of three novel agents, dasatinib, venetoclax and homoharringtonine, can improve…
- Conditions
- Acute Lymphoblastic Leukemia, Childhood Leukemia, Acute Lymphoblastic, T Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma
- Trial name
- CCCG-TALL-2025 (NCT06855810)
- Testing
- Venetoclax, Dasatinib, homoharringtonine
- Where
- 27 sites in China, Hong Kong
- Volunteers
- 610 people
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China